Sunvest International, Inc

Crown Capital Financial is a San Francisco-based firm specializing in commercial real estate financing, including equity investment and mortgage banking for various asset types. Their services also encompass real estate advisory and property management, driven by a knowledgeable in-house team that oversees a substantial portfolio in California and the West. Founded by David W. Yancey and Michael H. Yancey, Crown Capital aims to represent investors effectively in the acquisition and sale of both real property equity and debt. With a focus on providing comprehensive financial solutions, the firm has established itself as a trusted partner in the real estate market. Generated from the website

Marlowe Properties, based in San Rafael, CA, offers exclusive real estate listings and personalized services to clients seeking luxury properties. Their approach emphasizes individual attention and a commitment to finding unique, high-end homes for buyers and sellers. With a portfolio showcasing featured listings in prestigious locations such as St Helena and San Francisco, Marlowe Properties stands out for their curated selection of properties. Their team of experienced agents, including Marsha Abrahams and Michael Ackerman, brings a wealth of expertise and a client-focused mindset to every transaction. Generated from the website content

Sofinnova is a collaborative and experienced partner in the life sciences sector, specializing in transforming innovative biotech concepts into reality through comprehensive support in drug development, regulatory processes, and company building. With a strong portfolio that includes 115 funded companies, 53 IPOs, and 31 FDA-approved drugs, Sofinnova is committed to advancing medical care and improving lives through strategic investment and guidance. By teaming up with world-class entrepreneurs, Sofinnova aims to challenge the status quo of healthcare, leveraging over 120 years of operating experience and 100 years of investing expertise. The firm focuses on deploying both human and financial capital to turn visionary ideas into impactful biopharmaceutical solutions. Generated from the website